Top Suppliers:I want be here


1675-66-7

1675-66-7 structure
1675-66-7 structure
  • Name: Adelmidrol
  • Chemical Name: N,N'-bis(2-hydroxyethyl)nonanediamide
  • CAS Number: 1675-66-7
  • Molecular Formula: C13H26N2O4
  • Molecular Weight: 274.35700
  • Catalog: API Special medicine Dermatology medication
  • Create Date: 2016-01-14 11:22:03
  • Modify Date: 2024-01-02 16:55:02
  • Adelmidrol exerts important anti-inflammatory effects that are partly dependent on PPARγ. Adelmidrol reduces NF-κB translocation, and COX-2 expression.

Name N,N'-bis(2-hydroxyethyl)nonanediamide
Synonyms Adelmidrol
UNII-1BUC3685QU
Description Adelmidrol exerts important anti-inflammatory effects that are partly dependent on PPARγ. Adelmidrol reduces NF-κB translocation, and COX-2 expression.
Related Catalog
Target

NF-κB

COX-2

PPARγ

In Vitro Adelmidrol is a palmitoylethanolamide analogue. Adelmidrol reduces NF-κB translocation, COX-2, and p-ERK expression; proinflammatory cytokine release; and the incidence of nitrotyrosine and poly(ADP)ribose in the colon[1].
In Vivo Adelmidrol (10 mg/kg, o.s.) reduces significantly the degree and severity of the macroscopic and histologic signs of colon injury. Moreover, 4 days after colitis induced by dinitrobenzene sulfonic acid (DNBS) treatment, all mice have diarrhea and a reduction in body weight (compared with the sham groups). Adelmidrol (10 mg/kg, o.s.) treatment significantly reduces the loss of body weight. The inflammatory bowel disease (IBD) induced by DNBS intrarectally administered is also characterized by an augmentation in myeloperoxidase (MPO) activity, an indicator of neutrophil accumulating in the colon. This is consistent with light microscopic observations showing the colon of vehicle-treated DNBS mice to contain a large number of neutrophils. In contrast, Adelmidrol (10 mg/kg, o.s.) significantly reduces the degree of polymorphonuclear cell infiltration (determined as reduction in MPO activity) in inflamed colon[1].
Animal Admin Mice[1] Male adult CD1 mice (25-30 g) and male mice (20-27 g) are placed in a controlled environment and maintained on a 12-hour light/dark cycle with food and water available ad libitum. Mice are casually divided into the following groups (10 in each group) (1)Sham+vehicle group: Vehicle solution (saline) is given by oral administration for 4 days. (2) Sham+Adelmidrol (10 mg/kg): Administered o.s. for 4 days. (3) DNBS+vehicle: Mice are injected by DNBS as described, and vehicle (saline) is given o.s. each day for 4 days, starting 60 minutes after the injection of DNBS. (4) DNBS+Adelmidrol (10 mg/kg): Mice are injected by DNBS as described, and Adelmidrol (10 mg/kg) is given o.s. each day, starting 60 minutes after administration of DNBS[1].
References

[1]. Cordaro M, et al. Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease. Mol Pharmacol. 2016 Nov;90(5):549-561.

Density 1.097g/cm3
Boiling Point 596.4ºC at 760mmHg
Melting Point 132-134 ºC
Molecular Formula C13H26N2O4
Molecular Weight 274.35700
Flash Point 314.5ºC
Exact Mass 274.18900
PSA 98.66000
LogP 0.71590
Vapour Pressure 1.04E-16mmHg at 25°C
Index of Refraction 1.492
Storage condition 2-8℃
Water Solubility Soluble (60 g/L) (25 ºC)

~77%

1675-66-7 structure

1675-66-7

Literature: LIFEGROUP S.p.A. Patent: EP550008 A2, 1993 ;

~80%

1675-66-7 structure

1675-66-7

Literature: Lifegroup S.P.A. Patent: US5925678 A1, 1999 ;
Precursor  3

DownStream  0